Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-12-18, Stock:NVS, The news for the past five days is as follows:
2019-12-11: NEWS1: Top Research Reports for Novartis, AbbVie & Sanofi.NEWS2: Roche's (RHHBY) sBLA for Asthma Drug Xolair Accepted by FDA.NEWS3: The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint.
2019-12-12: NEWS1: Novartis (NVS) Gains But Lags Market: What You Should Know.NEWS2: The Zacks Analyst Blog Highlights: Novartis, AbbVie, Sanofi, Pioneer Natural Resources and Aqua America.NEWS3: Gilead Teams Up With Kiniksa, Submits BLA for CAR T Therapy.
2019-12-13: NEWS1: European Dividend Aristocrats: 41 Top-Flight International Dividend Stocks.NEWS2: FDA approves Sarepta's muscular dystrophy drug.NEWS3: Biotech Stocks Burn A Hole In Big Pharma's Pocket; Look For More Mergers In 2020.NEWS4: Biotech Stocks Are Poised to Rise in 2020, Analyst Says. Here Is His Top Pick..NEWS5: Paul Hudson seeks to write new prescription for Sanofi.
2019-12-16: NEWS1: Why this company ponied up $99M for a mid-Peninsula building.NEWS2: This Biotech Just Gave Up A Breakout — Why An Analyst Is Still Bullish.NEWS3: Amarin’s fish-oil pill now available to millions more patients. But it’s still no Lipitor.NEWS4: Regeneron Stock Is Downgraded. Analyst Cites Tough Competition From a Novartis Drug..NEWS5: Novartis Gets Positive CHMP Opinion for Wet AMD Drug Beovu.NEWS6: There’s more upside for biotech even after 24% gains in two months.
2019-12-17: NEWS1: Novartis' Asthma Candidate Fails in LUSTER Phase III Studies.

Answer: Decrease